Member Info for RichKen

Good to see a move upwards again!
The opportunities here are going to be huge!
Cheers RK

54retiresoon, the multiple revenue streams this company is pioneering will result in disruption of multiple opportunities across the sectors and taking control of sectors which will truly change treatments and safe health care businesses and nationalised services like our own NHS billions in expensive scans and lab work. The potential opportunity here the market has not understood which is very GM good news for current share holders. It is like buying Amazon shares for $1.46. We all wished we had been able to that! But this has more impact on global health today and into the future.
How am sorry feeling? Very excited!
Not long now!
Next RNS Friday or Monday is my hunch. Smelt one this morning and was not disappointed! We are ready!
Cheers RK

Good evening Investors and newcomers!
I normally try to add a few thoughts through the day, but to other business, commitments have been unable to do so!
So today's news is a very important step forward. This will not be the only distribution network but it is one focused on delivering to consumers, that is global online sales around the world and to specific business clients. We need a new type of distribution network and the experience of the founders of a fast-developing low-cost retail giant is a good place to open into the field for consumers. With global contacts in retail directly to consumers, this is great. Now we should not think for one minute that Cytiva and other partners will not also have opportunities to distribute the test in more specialist markets. This is not a normal medical test, it is a test the whole world needs and we need each partner to take a real interest in marketing the test to get it out there as quickly as possible.
One key point for me, is it is clear Avacta again have underlined their confidence that the test on LFA devices will work and will be huge. It is vital to get the distribution network in place prior to the product being available so you can make haste as required.
I see poeple mentioning Amazon and other options. These companies are huge, but they will not be focused as they don't have the motivation. I can't imagine Jeff Bezos taking the call from an English Biotech company CEO. But when the product gets out there he might take an interest! Yes I know anyone can set up a an Amazon shop but this needs focused marketing and distribution not a load of reviews on line! It is a binary product and it will work!
So we know that we are only weeks away. Maybe only three for Adeptrix and and a little longer for Cytiva. If it was sooner it would be perfect. But the approvals take time and we need it right.
What will we see next? Another partnership, news on another product all possible. This company is looking like we will have regular news updates and that is good.
If any are looking for fault, there is very little to fault here this is a multiple opportunity business with disruptive technology which will change the cause of medical diagnostics and therapeutics through the 2020's and in the meantime go from a development Biotech Business into one of the most important UK Biotech companies ever!
If you keep focused and hold here you will be very likely to be richly rewarded, sell-out and miss out is my own thoughts. I am not selling till we reach a full valuation and or we get bought out! You know where I see this going!
Keep researching and keep safe and strong!
Cheers, RK

Good morning all,
There is no doubt we are all going to be glued from now on the RNS alerts at 7am and when that next news comes it should be very interesting indeed!
Have a great day all!
Cheers RK

I have also had various looks at this with some experts in the field and I was looking at the broker notes and we were looking at margins and potentials in the global market.
The conclusion we arrived at was if a broker actually printed the potential earnings and profits to give a serious market capital value and share price in six to twelve months time no one would actually believe it as it is so high! Nobody is really wanting to put a number on it for fear of being laughed at! But the numbers I saw were very high indeed. This was going through the potential market opportunities for the partnerships in the presentation given earlier this month. The information is there if you look! Just take the number given yesterday for Lateral Flow Assay market where Affimer technology can just take the biggest slice of that market $9 billion per year!
This company could be on the edge of FSTE 250 / FTSE100 value within 2 years if they can stay independent and just make sure they build on the partnerships.
It is not surprising that a number of high net income individuals are building stakes here!
Cheers, RK

Finishing at 146/147. Is solid. The news will come and in the background there is a lot of interest in the work Avacta are working on. So you can be sure that when new comes it will be extremely positive ! The future upside is forecast to be strong.
So my position remains very excited!
Cheers RK

The most important point is Avacta owns the patent and the trademark to Affimer Technology, so if we consider the number of opportunities available to them where they can be used for diagnostics and in therapeutics they have everything in their control. That is why they want partnerships! The opportunities to fast track growth when you have the ability to develop solutions in around 8 weeks to new requirements which can then be marketed those to various clients who then have to pay the company for their use becomes one hugely valuable asset.
The only way the competion has to take on Avacta is to have a different solution which doesn’t impede the patent and that will be very difficult!
In this case the intellectual property is with the scientists. Even buying the business, if you don’t have the people it is not worth the acquisition! So for shareholders including company directors who hold that is very good news.
If we end up with multiple giant pharmaceutical companies all partnering with Avacta the sky is the limit here. Once they have on each project the approvals and certification then the number of opportunities for infinite revenue streams is enormous.
If they get this right in a few years time they could (not saying they will) become one of the most important and valuable Biotech companies in the world!
The weeks ahead are going to be very exciting indeed. For any who are new to this forum and want to see the multiple oppertunities, please do watch this presentation:
https://webcasting.brrmedia.co.uk/broadcast/5e985bc231da814c9fc6a477/5e9d8891f43115b1470001c7
I am very pleased I found this great opportunity and I hope you will be!
Cheers RK

What a day!
1. The Share price has risen by 11p to £1.49 - 7.97% - Perfect
2. Avacta has shared this exciting news to answer a few questions -https://avacta.com/lab-testing-vs-point-of-care-how-both-should-be-combined-to-provide-full-support-to-communities/
3. The market potential for Lateral Flow Assays is expected to be $9.65 billion by 2024 and is we assume as Affimer Technology is so good Avacta should be in a strong place to take a huge percentage of that market share!
4. We are a day cloaser to news from Cytiva and Adeptrix which will change the world of testing for the Covid19 virus forever!
5. Another day closer to new partnerships and further news with respect to https://avacta.com/sars-cov-2-neutralising-affimers-potential-for-a-covid-19-therapy/ which will mean we should see a safe and dependable treatment for Covid19.

The upside for investors is this is the Covid19 stock to be in right now as it has more advantages than the others!
Beyond Covid19 - then you better read the full report -https://avacta.com/preliminary-results-for-the-17-month-period-ending-31-december-2019/ which details multiple projects which are going to disrupt the healthcare industry a make pateints lifes much better and help clinical technicians reduce treatment side effects and get there patients on the road to faster recovery!

This company is great at keeping the world updated with news and unveiling new potentials solutions. It is not surprising new retail and large investors are coming on board every day!
Cheers, RK

With respect to Sona they don't have anything like the production capacity that the Cytiva / Avacta partnership will have the production capacity for Affimers is not restricted. Our key advantage in the market is the saliva and there is no pain and it will be easy to test and make no mistake so currently with swabs and sending away it takes too long and the swabs may not have enough of the sample to make a test result reliable.
We have the key advantage here! Production and supply will not be limited as they can produce to demand without restriction and the test will be so simple it will make test, track and trace as easy as 1, 2, 3!
The news from Cytiva will be coming back very soon and you can be sure it will be positive. Too many people are trying to make this complicated. It is not. The procedure for certification is something which will take the time but it is a formality which needs to be completed. The Affimers work, a LFD will work, they will know the Affimer will work on a LFD. If they didn't they would not have raised this to the market. It is coming and soon and when it does the 'Avacta Affimer Test' is what the world will be talking about - low cost, reliable and fast!
Today has been very good - SP £1.49 and when that RNS lands expect the spike of all spikes, it could be one of the biggest jumps of time! £3 to £5 will be achived and maintained before global sales takes this higher and higher.
I am expecting news very soon!
Cheers, RK

What is the agenda of the SCoutS and YellowF1 on this board?
It would appear when anyone comes here and try’s to contribute anything positive, you both do everything you can to bring disrespect and down play chances for VRFB’s
Just to say they are batteries no machines. Unfortunately the exCEO of RedT had an obsession with this term. Which caused market confusion.
The future of Invinity VRFB is based currently on standard systems with vanadium supplied by Bushveld with lower capex thanks to the leasing agreements which will make the system’s more cost effective than Lithium Ion systems. The safety and longevity of these systems as well as the ability to cycle so quickly will ensure a very bright future for this system.
Larger systems will replace gas peaker plants and this will be a huge contribution to the reduction of carbon emissions.
As the market develops there will be less lithium ion systems in this space and more flow batteries of which the vanadium based ones seem to have a very strong advantage.
I am sure Scott and Yellow will pull this apart!
This is a global opportunity and I am sure it will grow. Investors may not be so easy to find from LSE with these two trying to zap any enthusiasm out of potential investors. But as they are not selling or marketing the systems, they will have little effect on the future of this industry.
But what do I know I didn’t buy shares in RedT!
Cheers RK

As explained previously on this forum, if Avacta wants to be dual-listed it will need to change to the FTSE from AIM. It will need to be on a fully electronic system. This means no market maker.
Just in case anyone thinks that you need to be a certain market cap you don't, there are many examples for companies on the FTSE with lower market caps than us. But until we see an RNS say they are going to do this it is a pointless discussion.
However, it would be a very good thing to do both to move to the FTSE and be listed on multiple exchanges. Given where this business is heading it is almost certain they will do.
Cheers, RK

Great comparison tweet worth reading https://twitter.com/bigbitenow/status/1262355666221621249?s=21
Cheers RK

Thought I would check in! Invested heavily here, but looks like the regular contributors here are not!
If certain posters don’t like the company why don’t they sell up and go and make money elsewhere, rather than acting like spoiled children.
I am glad the new board and the company has a stronger outlook than some of the contributors here understand !
VRFB is a major part of the future of energy storage and this company has great potential and will offer superb solutions! In the UK and across the world. It would be more beneficial if people looked at the number of new energy storage opportunities around the globe.
People need to look at what is coming not the past.
Cheers RK

This board is busy and people read at lunch times to catch up. Good to post news items when the audience is at its peak lunch times and early evening. It’s the kind of read which every investor needs to read here.
Cheers RK

Definitely a worthy read - https://avacta.com/lab-testing-vs-point-of-care-how-both-should-be-combined-to-provide-full-support-to-communities/
Cheers RK

For me the likely close will be in the £1.62 to £1.68 window!

Still thinking we will see two strong RNS's this week, with a close on Friday with a £2.xx number. Depending on the news!

I think a Cytiva update and another partnership is very very likely!

If anyone thinks relaxing of lockdown is going to be expanding, I actually think without testing and finding away to to prove we are clear, we will end up in another extended lock down. So the sooner we have this mass testing ready the better. Ours with siliva is going to be the one. We have to have a test which everyone can use and it has to be binary! Yes or no!

It is coming and very soon!

Cheers, RK

Great start to the day and we are rising nicely!
Have a great week!
Expecting a close this week with a number beginning with a £2.??
Cheers RK

If that happened it would mean £48 per share. Investors might have to think for about 1mS to say ok and sounds fair. Most would pass out!
But I have a sneaky feeling if we are mega successful Alastair Smith might want more. Although he has a much larger holding than any claims made on this share chat by any! So he might be ok with that too. It depends if the motivation is finacial or changing the world to make it much better for more people.
I am sure the new owners would pay him a very good salary to stay on.
One day, it is possible, nothing here would surprise me. But not in 2020!
Cheers RK

I guess that is for tomorrow. I think a Friday close will be significantly higher than that. I have a few hunches that this could be a very strong week for Avacta!
Cheers RK

I would just like to inform you that I know Ophidian knows his stuff! No just picking up snippets he really knows his stuff in pharmaceuticals, so I would air caution and pick your discussions carefully! He has a mind worth picking, you may be better to cultivate discussions and get more rather than an opinion which may not be so well conversed. I have no idea of your background but I do Ophidian.
This is a gentle word in the ear, so do as you wish. Sometimes we need to pick fights wisely.
Let’s have a great week and work together here! Keep safe!
Cheers RK